KCNN4 and breast cancer: A member of the Calcium-activated subfamily, KCa3.1, was found to promote the acquisition of radioresistance in BC cells (Mohr et al., 2019), therefore it was suggested that targeting the channel during radiation therapy could result in radiosensitization of the tumor.